Drug Shortage Report for BEZALIP SR

Last updated on 2020-12-03 History
Report ID 128643
Drug Identification Number 02083523
Brand name BEZALIP SR
Common or Proper name Bezalip
Company Name ALLERGAN INC
Market Status MARKETED
Active Ingredient(s) BEZAFIBRATE
Strength(s) 400MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 30 tabs
ATC code C10AB
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2020-11-16
Estimated end date 2020-12-04
Actual end date 2020-12-02
Shortage status Resolved
Updated date 2020-12-03
Company comments
Health Canada comments
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-12-03 English Compare
v4 2020-12-02 French Compare
v3 2020-12-02 English Compare
v2 2020-11-19 French Compare
v1 2020-11-19 English Compare